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Abstract
This study set out to investigate the clinical diagnosis and treatment 
strategies for malignant breast adenomyoepithelioma (AME), thus 
increasing the clinical knowledge on such disease. Two patients with 
malignant breast AME in Beijing Friendship Hospital were selected 
for study. Here we report the diagnosis and treatment processes in 
terms of the failure experience and lessons and relate our findings to 
those in the literature. Malignant breast AME is inclined to affect the 
areola area. It is recommended to conduct simple mastectomy com-
bined with sentinel lymph node dissection due to the low sensitivity 
of the preoperative imaging diagnosis and difficulty in the pathologi-
cal diagnosis. Malignant breast AME features strong invasiveness and 
vulnerability to recurrence and metastasis. Therefore, the operative 
schemes and clinical treatment strategies should be formulated based 
on the comprehensive analyses of the physical signs, imageological 
examinations and pathology.
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Introduction
The glandular epithelium and myoepithelium of the breast 
simultaneously meet with the neoplastic proliferation which 
forms the lump with the significant realm, namely, adenomy-
oepithelioma (AME); such two kinds of lumps separately or 
simultaneously will undergo malignant transformation form-
ing the malignant AME. Cases of malignant breast AME are 
relatively rare and tend to be reported separately, so that there 
are no relevant diagnosis and treatment guidelines and mature 
clinical experience for reference. Two patients with malignant 
breast AME were admitted to the General Surgery Department 
of Beijing Friendship Hospital, Capital Medical University 
and this study summarized the failure, experiences and lessons 
learned from the diagnosis and treatment processes. The report 
is presented as follows.
Case Reports
Case 1
The patient, female, 58 years old, was admitted to the hos-
pital for 7 days due to a left breast neoplasm on September 
21, 2011. On physical examination, an approximately 3 × 3 
cm neoplasm was palpable behind the areola in the 9 o’clock 
direction of the left breast with a pliable but strong texture, 
clear border, poor activity and seemed to be adherent to the 
skin. On core needle biopsy pathology, the glandular tube 
and obvious cell nests under the extrusion were observed, 
thus it was recommended to conduct intraoperative frozen 
pathology. On September 27, 2011, the patient underwent ex-
tended resection of the left breast neoplasm, a 3.0 × 2.5 cm 
cyst-solid neoplasm. On frozen pathology, the proliferation 
of fibrous tissue and epithelial cell nests with large-scaled 
lesions were found and cells were slightly atypical with some 
glandular structures. After repeated sampling and immuno-
histochemical examinations, paraffin pathology examination 
was carried out, showing a malignant AME in the left breast. 
Immunohistochemical examination showed ER (-), PR (1% 
weakly +), Ki-67 (30%+), C-erbB-2 (+), CK5/6 (+), p63 
(partially +) and CD (partially +). The hospital contacted the 
patient and made repeated communications to recommend 
undergoing radical resection of the left breast cancer, but the 
patient refused.
On August 20, 2012, the patient was hospitalized again 
for 1 month due to ulceration of the left breast. On physical ex-
amination, an approximately 7 × 6 cm neoplasm was palpable 
in the left internal mammary area and fixed on the chest wall. 
The skin ulceration was found in the central area with about 
5 × 3.5 cm anabrosis, deep up to the pectoralis, the surface of 
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which was covered by yellow pus embryo; an approximately 
2 × 1 cm swollen lymph node was palpable in the left armpit. 
Chest CT showed the possibility of local recurrence or me-
tastasis (Fig. 1). Biopsy pathology of the anabrosis showed 
cancer infiltration. Core needle pathology of axillary lymph 
nodes showed cancerometastasis. The pus embryo bacteria at 
the anabrosis were cultured into Pseudomonas aeruginosa. No 
metastasis signs were seen by SPECT-bone scan.
The chemotherapy of TEC (docetaxel + epirubicin + cy-
clophosphamide) was carried out for two rounds but the tu-
mor did not shrink significantly. After the patient received the 
treatment of anti-infection and local and debridement, the pus 
embryo disappeared and no definite pathogenic bacteria were 
found during the repeated bacterial culture. However, the ana-
brosis did not shrink. On October 16, 2012, the radical opera-
tion of the left breast was performed successfully. On paraffin 
Figure 1. Chest CT (on Setpember 14, 2012): local soft tissues of the left breast were absent and the local skin incrassation was 
obvious. Subcutaneous irregular soft tissue density image was seen, the border of which with the residual mammary tissue was 
unclear and stretched inwards the muscle tissues and costal cartilages without definite damage in local rib sclerotin.
Figure 2. Chest wall Color Doppler ultrasound (on September 6, 2013): multiple flaky echoless region was observed below the 
incision of the left chest wall with the size of about 3.9 × 0.8 cm.
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pathology, a malignant AME was found in the left breast and 
the tumor had infiltrated into the skin and pectoralis with the 
distance from the deep resection margin < 0.1 cm. No tumor 
embolus was seen in the vessel and 1/12 cancer cells of axil-
lary lymph nodes had metastasized. Immunohistochemical ex-
amination showed ER (15% weakly +), PR (-), Ki-67 (30-40% 
+), C-erbB-2 (+), CK5/6 (+), p63 (partially +), CD10 (partially 
+), calponin (partially +) and CK8 (+). Auxiliary radiotherapy 
and chemotherapy were carried out. It was found that by the 
follow-up visit, the intractable subcutaneous hydrops appeared 
immediately after the operation (Fig. 2). According to the chest 
CT, bone destruction was seen in the sternum and the left fifth 
rib (Fig. 3). The patient died from pleural effusion and respira-
tory failure on August 23, 2014.
Case 2
The patient, female, 51 years old, was admitted to the hospital 
on October 14, 2009, 2 weeks after the right breast neoplasm 
was found. On color Doppler ultrasound, two approximately 
1.5 × 1.0 cm cyst-solid space-occupying lesions were seen 
near to the nipple in the 9 o’clock direction of the right breast 
and BIRADS-US was grade 4. On physical examination, an 
approximately 3 × 2 cm dumbbell-shaped neoplasm was pal-
pable behind the areola area in the 9 o’clock direction of the 
right breast with a pliable but strong texture, clear border and 
satisfactory activity. On October 17, 2009, the excision was 
conducted at the right breast section and frozen pathology was 
carried out, showing papilloma in the right breast duct. On par-
affin pathology, two cyst-solid lesions were observed in the 
section (diameter: 1.2 and 1.4 cm) with the papilloma in the 
peripheral duct of the right breast. After the operation, the pa-
tient recovered well and the follow-up visits were carried out 
regularly.
On September 17, 2014, the patient was hospitalized again 
1 month after the right breast neoplasm was found. On physi-
cal examination, an approximately 3.0 × 2.0 cm neoplasm was 
palpable behind the areola in the 9 o’clock direction of the 
right breast with a pliable but strong texture, clear border, poor 
activity which seemed to be adherent to the skin. On color 
Doppler ultrasound, the cyst-solid space-occupying lesion was 
Figure 3. Chest CT (on December 19, 2013): irregular low-density le-
sions were seen in front of sternum with the maximum cross-section of 
4.3 × 2.9 cm. The border with the incrassated skin and the chest wall 
were not clear and the bone destruction was found in the sternum and 
the left fifth rib with the vague edge seen in part of costal cartilages.
Figure 4. Breast color Doppler ultrasound (on September 17, 2014): a 2.1 × 2.0 cm cyst-solid space-occupying lesion was seen 
near to the nipple in the 9 o’clock direction of the right breast with the clear border and irregular form. Furthermore, the blood flow 
signal was found with the BI-RADS grading of 4a.
Articles © The authors   |   Journal compilation © World J Oncol and Elmer Press Inc™   |   www.wjon.org 129
Yuan et al World J Oncol. 2017;8(4):126-131
found in the 9 o’clock direction of the right breast with the 
BI-RADS of grade 4 (Fig. 4). On breast MRI, an abnormal sig-
nal was found in the right breast which may be the malignant 
tumor (Fig. 5).
On core needle biopsy pathology, the ductal epithelial 
and myoepithelial proliferation was found with atypical hy-
perplasia of part of the ductal epithelia. On September 20, 
2014, the extended resection for the right breast neoplasm 
was carried out to entirely remove the neoplasm and the ad-
jacent pectoralis major and fascia. On frozen pathology, one 
cyst-solid neoplasm with the diameter of 1.5 × 1.5 cm was 
found, diagnosed as a papilloma in the right breast duct. After 
a repeated sampling and immunohistochemical examination, 
a paraffin pathology examination was carried out, showing 
the small lesions (two or above will lead to ductal necrosis; 
the maximum diameter < 2 mm) were close to ductal car-
cinoma in situ; the tumor did not invade the pectoralis ma-
jor or the fascia. Immunohistochemical examination showed 
ER (-), PR (-), C-erbB-2 (+), Ki-67 (20%), E-cadherin (+), 
CK8 (+), p63 (myoepithelium +) and CK5/6 (+/-). Pathology 
consultation in another hospital showed AME canceration 
(myoepithelial carcinoma/malignant adenomyoepithelioma) 
and part of canceration in the duct. The pathology specimen 
taken on October 17, 2009 was re-sampled and a review was 
conducted; finally, the diagnosis results were right breast my-
oepithelioma.
On October 20, 2014, the patient underwent simple mas-
tectomy of the right breast plus sentinel lymph node biopsy 
(SLNB) with satisfactory results. On postoperative pathology, 
the original lesions were excised without the residual; a highly 
differentiated infiltrating lesion of the ductal carcinoma (grade 
1, 5 points) with a diameter of 1 cm was seen in the 3 o’clock 
direction of the right breast with 0/5 cancer metastasis of the 
sentinel LN. Immunohistochemical examination showed ER 
(80% strongly +), PR (-), C-erbB-2 (+), Ki-67 (5%), E-cadher-
in (+), P120 (membrane +), CK8 (+), CK5/6 (-), p63 (-), CD10 
(-), GFAP (-) and calponin (-). The auxiliary postoperative 
chemotherapy EC (epirubicin + cyclophosphamide) combined 
with sequential T (Taxol) was conducted for eight rounds. At 
the same time, the patient underwent endocrinotherapy. After 
close follow-up visits over 21 months, the general condition of 
the patient was satisfactory.
Discussion
Histologic features
The malignant breast AME may occur alone, with part of such 
a tumor becoming malignant from the AME by combining 
with the infiltrating ductal carcinoma [1]. The malignant AME 
and infiltrating ductal carcinoma lesions respectively were 
found at the ipsilateral breast of the second patient as stated, 
which is consistent with the literature [2].
Immunophenotyping
The malignant AME may express myoepithelial markers of the 
basal cells to varying extents such as CK5/6, p63 and SMA, 
other than ER, PR and Her-2, thus the phenotype features the 
basal-like breast carcinoma [3]. Two cases in the study group 
both exhibited the above feature: the first case: ER (-), PR(1% 
weakly +), Ki-67 (30% +), C-erbB-2 (+), CK5/6 (+), p63 (par-
tially +) and CD (partially +); the second case: ER (-), PR (-), 
C-erbB-2 (+), Ki-67 (20%), E-cadherin (+), CK8 (+), p63 (my-
oepithelium +) and CK5/6 (+/-).
Figure 5. Breast MRI (on September 19, 2014): one about 2.3 × 1.8 × 2.8 cm abnormal signal image with the irregular form was 
observed in the outer quadrant of the right breast with the equal T1 and long T2 signals. The border was unclear with the burr 
at the margin. The near skin incrassated and the nipple was inverted. What’s more, the border of local lesion with the pectoralis 
major was unclear. SI-TIME curve: the curve in the high-signal area of the lesion featured type II.
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Predilection site of tumor
There are definite literature reports on the predilection site of 
tumor at home, the reason for which may be that the patholo-
gists frequently reporting such cases pay more attention to the 
histology and immunohistochemical examination of such rare 
cases. The tumors of two cases in another study group initially 
occurred in the areola area of five cases reported by Pei et al 
[4], with these two cases conforming to the above, while Yang 
et al [5] reported one case. The author made the analysis that 
this phenomenon may be correlated to the histogenesis of ma-
lignant AME, because the myoepithelial cells usually lie be-
tween the breast ducts and the basal layers of acinus and the 
major breast ducts aggregate in the areola area with abundant 
myoepithelial cells.
Sensibility of preoperative imaging diagnosis
The initial color Doppler ultrasound examination results of the 
two cases in the group both showed the cyst-solid neoplasm 
in the areola area with the BI-RADS grading of 4a. Accord-
ing to the suggestions from Guideline and Specification for the 
Diagnosis and Treatment of Breast Cancer (version 2015) by 
Chinese Anti-Cancer Association, grade 4a lesion tends to be 
benign with the conformity rate to the malignancy of 2-10% 
[6]. In terms of the second case in the group, the preoperative 
MRI showed that the border of local lesions with the pectoralis 
major was unclear (Fig. 5), while the postoperative pathology 
certified that the tumor did not invade the pectoralis major and 
fascia. Therefore, the author believed that the preoperative im-
aging diagnosis of such case featured the low sensitivity and 
the physicians with rich clinical experience shall make com-
prehensive analysis on the patient signs, imaging and pathol-
ogy for the definite diagnosis without the missed diagnosis.
Preoperative pathological diagnosis
With the limitation of the rarity and lack of the relevant ex-
perience, it is difficult to specify the nature by the intraopera-
tive frozen pathology [7]. However, the complete and accurate 
pathological diagnosis is the important premise and founda-
tion for the selection of operation methods and clinical treat-
ment, thus it is required to flexibly select the neoplasm biopsy 
methods. A few tissues of two cases in the paper were obtained 
through the core needle aspiration biopsy, thus the pathogen-
esis failed to be identified; instead, the excisional biopsy was 
carried out and the specific pathological diagnosis was ob-
tained before the operation through the repeated sampling, sec-
tion, immunohistochemical test and pathology consultation.
Operation methods of breast
The domestic scholars did not provide the definite conclusion 
on the selection of breast operation methods. Some scholars 
have suggested conducting the simple mastectomy or extended 
resection or breast-conserving surgery on the foundation that 
safe resection margin will be obtained and local radiotherapy 
will be conducted flowingly. For the first patient in the paper, 
the pathogenesis was clear through the locally extended resec-
tion, but the simple mastectomy was not operated. It turned 
out that the patient suffered from the local recurrence and 
the skin ulceration 11 months after the operation. The patient 
died from the comprehensive recurrence of the chest wall and 
bone metastases 10 months after the radical mastectomy of the 
right breast. For the second patient, the local recurrence and 
malignant transformation appeared and the infiltrating ductal 
carcinoma was combined 5 years after the segment resection 
of the AME but there were no positive signs in the palpation-
negative lesions during the preoperative color Doppler ultra-
sound and MRI examinations. The disease features strong lo-
cal invasiveness and inclination to recurrence and metastasis 
and tends to combine with the infiltrating ductal carcinoma 
and other lesions which cannot be found by the imageological 
examination. If the pathological diagnosis is clear, the author 
recommends the simple mastectomy rather than local extended 
resection or breast-conserving surgery.
Operation method of regional lymph nodes
A few lymph nodes of malignant AME metastasized. Ahmed 
et al [8] made the close follow-up visits to 12 cases with the 
bi-differentiation, where the pulmonary metastasis appeared 
in three cases and brain metastasis in two cases without none 
of cases with lymphatic metastasis. Pei et al [4] reported five 
patients with the malignant AME which all underwent the ax-
illary lymph nodes dissection without the lymph node metas-
tasis. Of two cases with the comprehensive recurrence of the 
chest wall and bone metastases after the operation, one patient 
died, but no axillary lymph node metastasis was found in the 
close follow-up visit. The first patient in the paper suffered 
from the recurrence and skin ulceration after the local extend-
ed resection and there was 1/12 the axillary LN cancerome-
tastasis after the radical resection of the left breast cancer. The 
second patient underwent the SLNB with 0/5 cancerometas-
tasis. Further discussions are required to specify whether it is 
applicable to conduct the SLNB without the axillary lymph 
nodes dissection. What’s worse, there are definite conclusions 
in the literatures at home and abroad. The author thinks that 
the simple mastectomy combined with SLNB is the preferred 
operation method.
Adjuvant systemic treatment
The hematogenous metastasis of malignant AME is common 
including the liver, brain, bone, and thyroid metastases and the 
prognosis of patients is extremely poor with the metastasis [9, 
10]. Bult et al [11] reviewed such case and found that one-third 
patients suffered from distant metastases and local recurrence 
which tend to occur 4 months to 2 or 3 years after the first 
diagnosis. Based on the features of strong invasiveness and 
tendency to recurrence and metastasis, the scholars at home 
and abroad all recommended the adjuvant chemotherapy. Be-
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cause the ER and PR tend to be negative, the endocrinotherapy 
was deprecated. The first patient in the paper did not undergo 
the operation and receive the adjuvant radiochemotherapy, al-
though the pathology was clear; 11 months after the operation, 
the local recurrence occurred. The lesions were insensitive to 
the salvage chemotherapy and became malignant. Finally, the 
patient died from the comprehensive recurrence of the chest 
wall and bone metastases 10 months after the radical resection. 
For the second patient in the paper, with the malignant AME 
combined with the infiltrating ductal carcinoma, the adjuvant 
chemotherapy was carried out; because the hormone receptor 
of infiltrating ductal carcinoma was positive, the endocrino-
therapy has been conducted with the close follow-up visit for 
21 months and the general condition of the patient was satis-
factory.
The cases with malignant breast AME are rare and such 
disease is characterized by the strong invasiveness and vulner-
ability to recurrence and metastasis. Currently, there is no ma-
ture clinical experience for reference. Such tumor is inclined to 
affect the areola area. It is recommended to conduct the simple 
mastectomy combined with the SLNB due to the low sensitiv-
ity of the preoperative imaging diagnosis and difficulty in the 
pathological diagnosis.
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